HomeNewsIndiaCOVID-19 vaccines | Not necessary to keep 25% doses for private sector, supply only what they buy: Centre tells jab makers

COVID-19 vaccines | Not necessary to keep 25% doses for private sector, supply only what they buy: Centre tells jab makers

The private sector being unable to pick 25 percent of the COVID-19 vaccine dose supply is being seen as a hindrance to the vaccination drive's pace.

August 04, 2021 / 12:45 IST
Story continues below Advertisement
Representative image: Reuters
Representative image: Reuters

The Centre has told the vaccine manufacturers that they do not need to keep 25 percent of their produce for private manufacturers and can supply to them only as much they buy, giving the rest of the doses to the government.

Union Health Minister Mansukh Mandaviya told Parliament in an oral answer on August 3 that it is not necessary for the manufacturers to give 25 percent doses in the private quota. News18 was the first to report on July 28 that the government was planning to reduce the 25 percent quota of vaccination supply for private hospitals, given their subdued response, and procure more on its end for supplies to states which have been asking for more doses citing their higher capacity to vaccinate people.

Story continues below Advertisement

News18 had reported that private sector was unable to pick 25 percent of the supplies and this was hindering pace of the vaccination drive.

“We have seen in one month that in the private sector, 25 percent vaccines are not being utilized. Only 7-9 percent of the vaccines are being used in the private sector. So we have decided that vaccines not being utilised in the private hospitals be given in the government quota. Government has told all the companies … that it is not necessary to give 25 percent vaccines in the private quota. Give private hospitals as much as they buy, rest the government will take their supplies,” Health Minister Mansukh Mandaviya told Parliament.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show